Back to ALNY

ALNYLAM PHARMACEUTICALS, INC. Proceeds from Stock Issuance 2008-2021 | ALNY

Beta

What is ALNYLAM PHARMACEUTICALS, INC.'s current proceeds from stock issuance?

ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual proceeds from stock issuance for 2021 was $0, a NaN% decline from 2020. ALNYLAM PHARMACEUTICALS, INC. proceeds from stock issuance for the quarter ending December 31, 2020 was $0.

What was ALNYLAM PHARMACEUTICALS, INC.'s proceeds from stock issuance in 2020?

ALNYLAM PHARMACEUTICALS, INC. annual proceeds from stock issuance for 2020 was $0, a 100.00% decline from 2019.

What was ALNYLAM PHARMACEUTICALS, INC.'s proceeds from stock issuance in 2019?

ALNYLAM PHARMACEUTICALS, INC. annual proceeds from stock issuance for 2019 was $381.9M, a Infinity% increase from 2018.

Proceeds from Stock Issuance History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGRN/A
FY2015
$496.4M
→
FY2021
$0
0809101213151718192021
5 years selected
Proceeds from Stock Issuance History
PeriodValueChangeSource
FY2021$0-10-K
FY2020$0-100.0%10-K
FY2019$381.9M-10-K
FY2018$0-100.0%10-K
FY2017$1.14B+129.6%10-K
FY2015$496.4M+186.0%10-K
FY2013$173.6M+100.0%10-K
FY2012$86.8M+8641.2%10-K
FY2010$993,000-14.0%10-K
FY2009$1.2M-78.7%10-K
FY2008$5.4M-10-K
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →